Egalet Corp., a Wayne, Pa.-based maker of pain treatments, appointed John Varian to its board of directors.
Varian was most recently the CEO and director of antibodies developer XOMA Corp., where he led the refocusing and refinancing of the company.
Varian, who also sits on the boards of SELLAS Life Sciences Group Inc. and Versartis Inc., has helped companies establish strategic direction, raise capital and launch pharmaceutical products, the company said in a statement.
"John's successful thirty-five-year career working with biotechnology and specialty pharmaceutical companies will be valuable as we execute on our growth strategy. Specifically, his financial and operational experience will be helpful as we focus on commercial execution and business development," Egalet Chairman Timothy Walbert said in a statement.
Egalet is seeking partners for Egalet-002 — an opioid medication for pain.
